Literature DB >> 2104794

Long-term follow-up of nocturnal ventilatory assistance in patients with respiratory failure due to Duchenne-type muscular dystrophy.

C H Mohr1, N S Hill.   

Abstract

We followed eight patients with Duchenne-type muscular dystrophy for an average of 39 months after initiation of noninvasive intermittent ventilatory assistance using body ventilators. After one to three months of nocturnal use averaging 8 h, mean daytime PaCO2 fell from 63 +/- 2 to 45 +/- 3 mm Hg. At late follow-up, PaCO2 remained stable at 47 +/- 4 mm Hg, but vital capacity fell 33 percent compared with the initial value and the average duration of ventilator use had increased to 18 +/- 2 h daily. Three patients died and five survived; two continued using negative pressure ventilators and three had tracheostomies placed for administration of positive pressure ventilation. We conclude that noninvasive intermittent ventilatory assistance effectively reverses hypoventilation and symptoms in patients with late-stage Duchenne muscular dystrophy, but pulmonary function continues to deteriorate necessitating longer periods of ventilation, and often tracheostomy, within a few years.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104794     DOI: 10.1378/chest.97.1.91

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

Review 1.  Approaching a new age in Duchenne muscular dystrophy treatment.

Authors:  Kathryn R Wagner
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

2.  Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy.

Authors:  A K Simonds; F Muntoni; S Heather; S Fielding
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

Review 3.  Breathing in Duchenne muscular dystrophy: translation to therapy.

Authors:  Doreen Z Mhandire; David P Burns; Angela L Roger; Ken D O'Halloran; Mai K ElMallah
Journal:  J Physiol       Date:  2022-06-24       Impact factor: 6.228

Review 4.  Negative-Pressure Ventilation in Neuromuscular Diseases in the Acute Setting.

Authors:  Anna Annunziata; Cecilia Calabrese; Francesca Simioli; Antonietta Coppola; Martina Flora; Antonella Marotta; Valentina Di Spirito; Francesco Didonna; Marcellino Cicalese; Giuseppe Fiorentino
Journal:  J Clin Med       Date:  2022-05-06       Impact factor: 4.964

Review 5.  Respiratory aspects of neurological disease.

Authors:  M I Polkey; R A Lyall; J Moxham; P N Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

Review 6.  Molecular-targeted therapy for Duchenne muscular dystrophy: progress and potential.

Authors:  Anthony Scimè; Michael A Rudnicki
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

7.  Obstructive apnoeas in Duchenne muscular dystrophy.

Authors:  Y Khan; J Z Heckmatt
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

8.  Sleep related breathing patterns in patients with spinal muscular atrophy.

Authors:  R Manni; I Cerveri; A Ottolini; F Fanfulla; M C Zoia; G Lanzi; A Tartara
Journal:  Ital J Neurol Sci       Date:  1993-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.